Overexpression of EphA2 correlates with epithelial–mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients

The expression of EphA2 and three epithelial–mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry in human gastric cancer and normal gastric mucosa. The expression of EphA2 and vimentin was significantly higher in gastric cancer tissues th...

Full description

Saved in:
Bibliographic Details
Published inMedical oncology (Northwood, London, England) Vol. 29; no. 4; pp. 2691 - 2700
Main Authors Hou, Futao, Yuan, Weijie, Huang, Jin, Qian, Liyuan, Chen, Zhikang, Ge, Jie, Wu, Shaobin, Chen, Jinxiang, Wang, Jixu, Chen, Zihua
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.12.2012
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The expression of EphA2 and three epithelial–mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry in human gastric cancer and normal gastric mucosa. The expression of EphA2 and vimentin was significantly higher in gastric cancer tissues than in normal gastric mucosa tissues, and similar results were found for negative E-cadherin expression and ectopic β-catenin expression. Further analysis showed that the expression of EphA2 was closely correlated with the depth of tumor invasion, tumor–node–metastasis (TNM) stages and lymph node metastasis. Down-regulated expression of the epithelial protein E-cadherin, overexpression of the mesenchymal protein vimentin and ectopic expression of β-catenin were associated with the depth of tumor invasion, tumor differentiation, TNM stages and lymph node metastasis. The Spearman rank test indicated that the positive expression of EphA2 was negatively associated with E-cadherin expression and was positively correlated with β-catenin ectopic expression and vimentin expression. In addition, the Kaplan–Meier survival analysis showed that the overexpression of EphA2 and vimentin, ectopic expression of β-catenin and down-regulation of E-cadherin indicate a poor outcome. Moreover, multivariate Cox analysis showed that TNM stages, lymph node metastasis, EphA2 expression, E-cadherin expression and β-catenin ectopic expression were independent prognostic factors for postoperative gastric cancer. These findings indicate that the overexpression of EphA2 correlates with the loss of epithelial proteins and the appearance of mesenchymal proteins. Therefore, EphA2 may play a role in epithelial–mesenchymal transition in gastric cancer.
AbstractList The expression of EphA2 and three epithelial-mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry in human gastric cancer and normal gastric mucosa. The expression of EphA2 and vimentin was significantly higher in gastric cancer tissues than in normal gastric mucosa tissues, and similar results were found for negative E-cadherin expression and ectopic β-catenin expression. Further analysis showed that the expression of EphA2 was closely correlated with the depth of tumor invasion, tumor-node-metastasis (TNM) stages and lymph node metastasis. Down-regulated expression of the epithelial protein E-cadherin, overexpression of the mesenchymal protein vimentin and ectopic expression of β-catenin were associated with the depth of tumor invasion, tumor differentiation, TNM stages and lymph node metastasis. The Spearman rank test indicated that the positive expression of EphA2 was negatively associated with E-cadherin expression and was positively correlated with β-catenin ectopic expression and vimentin expression. In addition, the Kaplan-Meier survival analysis showed that the overexpression of EphA2 and vimentin, ectopic expression of β-catenin and down-regulation of E-cadherin indicate a poor outcome. Moreover, multivariate Cox analysis showed that TNM stages, lymph node metastasis, EphA2 expression, E-cadherin expression and β-catenin ectopic expression were independent prognostic factors for postoperative gastric cancer. These findings indicate that the overexpression of EphA2 correlates with the loss of epithelial proteins and the appearance of mesenchymal proteins. Therefore, EphA2 may play a role in epithelial-mesenchymal transition in gastric cancer.[PUBLICATION ABSTRACT]
The expression of EphA2 and three epithelial-mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry in human gastric cancer and normal gastric mucosa. The expression of EphA2 and vimentin was significantly higher in gastric cancer tissues than in normal gastric mucosa tissues, and similar results were found for negative E-cadherin expression and ectopic β-catenin expression. Further analysis showed that the expression of EphA2 was closely correlated with the depth of tumor invasion, tumor-node-metastasis (TNM) stages and lymph node metastasis. Down-regulated expression of the epithelial protein E-cadherin, overexpression of the mesenchymal protein vimentin and ectopic expression of β-catenin were associated with the depth of tumor invasion, tumor differentiation, TNM stages and lymph node metastasis. The Spearman rank test indicated that the positive expression of EphA2 was negatively associated with E-cadherin expression and was positively correlated with β-catenin ectopic expression and vimentin expression. In addition, the Kaplan-Meier survival analysis showed that the overexpression of EphA2 and vimentin, ectopic expression of β-catenin and down-regulation of E-cadherin indicate a poor outcome. Moreover, multivariate Cox analysis showed that TNM stages, lymph node metastasis, EphA2 expression, E-cadherin expression and β-catenin ectopic expression were independent prognostic factors for postoperative gastric cancer. These findings indicate that the overexpression of EphA2 correlates with the loss of epithelial proteins and the appearance of mesenchymal proteins. Therefore, EphA2 may play a role in epithelial-mesenchymal transition in gastric cancer.
Author Wang, Jixu
Huang, Jin
Chen, Zhikang
Qian, Liyuan
Chen, Zihua
Wu, Shaobin
Chen, Jinxiang
Ge, Jie
Hou, Futao
Yuan, Weijie
Author_xml – sequence: 1
  givenname: Futao
  surname: Hou
  fullname: Hou, Futao
  organization: Department of General Surgery, Xiangya Hospital, Central South University
– sequence: 2
  givenname: Weijie
  surname: Yuan
  fullname: Yuan, Weijie
  organization: Department of General Surgery, Xiangya Hospital, Central South University
– sequence: 3
  givenname: Jin
  surname: Huang
  fullname: Huang, Jin
  organization: Department of Oncology, Xiangya Hospital, Central South University
– sequence: 4
  givenname: Liyuan
  surname: Qian
  fullname: Qian, Liyuan
  organization: Department of General Surgery, The Third Xiangya Hospital, Central South University
– sequence: 5
  givenname: Zhikang
  surname: Chen
  fullname: Chen, Zhikang
  organization: Department of General Surgery, Xiangya Hospital, Central South University
– sequence: 6
  givenname: Jie
  surname: Ge
  fullname: Ge, Jie
  organization: Department of General Surgery, Xiangya Hospital, Central South University
– sequence: 7
  givenname: Shaobin
  surname: Wu
  fullname: Wu, Shaobin
  organization: Department of General Surgery, Xiangya Hospital, Central South University
– sequence: 8
  givenname: Jinxiang
  surname: Chen
  fullname: Chen, Jinxiang
  organization: Department of General Surgery, Xiangya Hospital, Central South University
– sequence: 9
  givenname: Jixu
  surname: Wang
  fullname: Wang, Jixu
  organization: Department of General Surgery, Xiangya Hospital, Central South University
– sequence: 10
  givenname: Zihua
  surname: Chen
  fullname: Chen, Zihua
  email: chenzihua1@hotmail.com
  organization: Department of General Surgery, Xiangya Hospital, Central South University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22189617$$D View this record in MEDLINE/PubMed
BookMark eNp1kctu1TAQhi1URC_wAGyQJTZsAh47ieNlVZWLVKkbkNhFPj6Tc1wldrB9WrrjHXgKXosnYaIUhJCwZI_l-f7x2P8pOwoxIGPPQbwGIfSbDFIoWQkAmlJX8hE7gaYxFSj4fER71ehKNK04Zqc53wghoZHmCTuWEjrTgj5hP65vMeHXOWHOPgYeB345788ldzElHG3BzO982XOcacXR2_Hnt-8TZgxufz_ZkZdkQ_aFxNUq2PI5xYI-ZO4D39lcknfc2eAwcRu2nOr4tEC7EHOhnJ_mmMoC8CFShk7jjMkWf4t8poCh5Kfs8WDHjM8e4hn79Pby48X76ur63YeL86vKKS1LpehloDurBmhhK6TTWLtu0xnVymHQelNbhKZuG-MGo-hLamNb1VoYHFpErc7Yq7UuNfjlgLn0k88Ox9EGjIfcA42uVY1oCX35D3oTDylQdz0I04AxupZEwUq5FHNOOPRz8pNN9wT1i4_96mNPPvaLj_2iefFQ-bCZcPtH8ds4AuQKZEqFHaa_r_5f1V9Oxa9P
CODEN MONCEZ
CitedBy_id crossref_primary_10_7314_APJCP_2015_16_7_2777
crossref_primary_10_18632_oncotarget_9802
crossref_primary_10_3892_ol_2019_10677
crossref_primary_10_1007_s11033_020_05767_y
crossref_primary_10_1007_s11010_014_2164_6
crossref_primary_10_1111_cas_12556
crossref_primary_10_1016_j_jconrel_2019_08_006
crossref_primary_10_1177_030089161309900608
crossref_primary_10_3390_cancers10030063
crossref_primary_10_1038_s41388_021_01786_6
crossref_primary_10_1021_pr300212g
crossref_primary_10_1016_j_mcpro_2021_100131
crossref_primary_10_1016_j_arabjc_2022_104211
crossref_primary_10_1016_j_abb_2021_109024
crossref_primary_10_3892_ol_2014_2196
crossref_primary_10_1007_s00432_018_2683_8
crossref_primary_10_3748_wjg_v20_i34_12313
crossref_primary_10_1002_ijc_27947
crossref_primary_10_1038_s41388_018_0341_x
crossref_primary_10_1016_j_prp_2018_07_014
crossref_primary_10_1155_2022_4220786
crossref_primary_10_1186_s40425_019_0679_9
crossref_primary_10_1128_mBio_02892_18
crossref_primary_10_3109_08977194_2014_984806
crossref_primary_10_1007_s12032_012_0305_x
crossref_primary_10_1186_s12885_017_3875_3
crossref_primary_10_1111_iep_12219
crossref_primary_10_3748_wjg_v21_i33_9707
crossref_primary_10_1007_s11033_022_08045_1
crossref_primary_10_1007_s00432_021_03618_2
crossref_primary_10_3390_cells9020513
crossref_primary_10_1038_s41419_018_1164_y
crossref_primary_10_1016_j_ejca_2013_03_014
crossref_primary_10_3109_08977194_2014_982276
Cites_doi 10.1007/s13277-010-0068-y
10.1136/jcp.2010.076026
10.1007/s10911-010-9178-9
10.1038/modpathol.2009.19
10.1002/cncr.24335
10.1080/00313020701329914
10.1111/j.1872-034X.2009.00563.x
10.1038/nrc822
10.4161/cbt.5.10.3225
10.1158/1078-0432.CCR-0157-03
10.1038/onc.2008.204
10.4161/cbt.7.7.6168
10.1158/0008-5472.CAN-08-4153
10.1158/1078-0432.CCR-09-0473
10.1242/jcs.017145
10.2174/1568009053765780
10.1016/j.cell.2009.11.007
10.1083/jcb.200910041
10.1111/j.1349-7006.2004.tb03194.x
10.1016/S0092-8674(02)00685-2
10.1016/S0140-6736(03)13975-X
10.1387/ijdb.072410mn
10.1016/S0016-5085(97)70218-X
10.1007/s004280000283
10.1002/cncr.22415
10.1016/j.devcel.2009.06.016
10.1371/journal.pone.0012794
10.1007/s12253-008-9132-y
10.1023/A:1006572204497
10.1007/s10555-008-9169-0
10.1111/j.1365-2559.2009.03247.x
10.1007/s10555-008-9179-y
10.1007/s10620-008-0649-4
10.1016/j.ceb.2005.08.001
10.1038/onc.2009.302
10.4161/cbt.5.2.2510
10.1158/1078-0432.CCR-03-0589
10.1002/ijc.24798
10.3748/wjg.v8.i6.987
10.1002/jso.21493
10.4161/cbt.6.2.3629
10.1097/01.sla.0000149300.28588.23
ContentType Journal Article
Copyright Springer Science+Business Media, LLC 2011
Springer Science+Business Media New York 2012
Copyright_xml – notice: Springer Science+Business Media, LLC 2011
– notice: Springer Science+Business Media New York 2012
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s12032-011-0127-2
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Academic Eastern Edition
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1559-131X
EndPage 2700
ExternalDocumentID 2782371341
10_1007_s12032_011_0127_2
22189617
Genre Research Support, Non-U.S. Gov't
Journal Article
Feature
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
2.D
203
28-
29M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
3V.
4.4
406
408
40E
53G
5GY
5RE
5VS
6NX
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYFA
AAYIU
AAYQN
AAYTO
ABDZT
ABECU
ABFGW
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBYP
ACCUX
ACGFS
ACHSB
ACHVE
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACTTH
ACUDM
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEEQQ
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFEXP
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GRRUI
HF~
HG6
HMCUK
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXD
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NDZJH
NF0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OVD
P19
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
PZZ
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TT1
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
YLTOR
Z7U
Z82
Z83
Z87
Z8O
Z8V
Z91
ZMTXR
ZOVNA
ZXP
~A9
~EX
AACDK
AAEOY
AAJBT
AASML
AAYZH
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
AJOOF
ALIPV
CGR
CUY
CVF
ECM
EIF
H13
NPM
SJYHP
AAYXX
CITATION
7XB
8FK
K9.
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c372t-3189178a3f161d02c7e4c8b89362ff77b4ae154659cf9300249a636a1fceaee73
IEDL.DBID 7X7
ISSN 1357-0560
IngestDate Fri Oct 25 03:09:43 EDT 2024
Thu Oct 10 18:00:25 EDT 2024
Thu Sep 12 18:03:56 EDT 2024
Tue Oct 15 23:49:04 EDT 2024
Sat Dec 16 12:03:17 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Immunohistochemistry
Epithelial–mesenchymal transition
Prognosis
Gastric cancer
EphA2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c372t-3189178a3f161d02c7e4c8b89362ff77b4ae154659cf9300249a636a1fceaee73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 22189617
PQID 1095199742
PQPubID 30753
PageCount 10
ParticipantIDs proquest_miscellaneous_1111863506
proquest_journals_1095199742
crossref_primary_10_1007_s12032_011_0127_2
pubmed_primary_22189617
springer_journals_10_1007_s12032_011_0127_2
PublicationCentury 2000
PublicationDate 2012-12-01
PublicationDateYYYYMMDD 2012-12-01
PublicationDate_xml – month: 12
  year: 2012
  text: 2012-12-01
  day: 01
PublicationDecade 2010
PublicationPlace Boston
PublicationPlace_xml – name: Boston
– name: United States
– name: Middlesex
PublicationTitle Medical oncology (Northwood, London, England)
PublicationTitleAbbrev Med Oncol
PublicationTitleAlternate Med Oncol
PublicationYear 2012
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Yang, Yuan, He (CR19) 2009; 39
Dicken, Bigam, Cass (CR2) 2005; 241
Lu, Shahzad, Wang (CR5) 2008; 7
Benjamin, Kwiatkowski, Yang (CR11) 2010; 189
Tomita, van Bokhoven, van Leenders (CR9) 2000; 60
Prudkin, Liu, Ozburn (CR18) 2009; 22
Zhou, Li, Wu (CR31) 2010; 31
Kamat, Coffey, Merritt (CR23) 2009; 115
Brannan, Dong, Prudkin (CR21) 2009; 15
Jawhari, Jordan, Poole (CR16) 1997; 112
Cui, Lee, Yu (CR20) 2010; 126
Fuyuhiro, Yashiro, Noda (CR44) 2010; 30
Zhou, Ran, Tang (CR17) 2007; 6
Thaker, Deavers, Celestino (CR14) 2004; 10
Hsu, Shan, Jin (CR42) 2010; 101
Gilles, Polette, Mestdagt (CR46) 2003; 63
Micalizzi, Farabaugh, Ford (CR8) 2010; 15
Lin, Han, Kamat (CR15) 2007; 109
Almeida, Ferreira, Santos (CR30) 2010; 63
Merrit, Thaker, Landen (CR24) 2006; 5
Schmalhofer, Brabletz, Brabletz (CR10) 2009; 28
Huber, Kraut, Beug (CR13) 2005; 17
Lovatt, Bijlmakers (CR37) 2010; 5
Hess, Seftor, Gardner (CR3) 2001; 61
MacDonald, Tamai, He (CR33) 2009; 17
Wong, Lo, Lee (CR41) 2004; 10
Polette, Gilles, de Bentzmann (CR45) 1998; 16
Thiery, Acloque, Huang (CR7) 2009; 139
Zhou, Xu, Han (CR40) 2002; 8
Hess, Seftor, Gruman (CR48) 2006; 5
Wang, Sun, Allgayer (CR38) 2010; 29
Yilmaz, Christofori (CR29) 2009; 28
Fukuyama, Niculaita, Ng (CR36) 2008; 27
Kataoka, Igarashi, Kanamori (CR25) 2004; 95
Hohenberger, Gretschel (CR1) 2003; 362
Guarino, Rubino, Ballabio (CR32) 2007; 39
Yuan, Ge, Chen (CR49) 2009; 54
Guarino, Rubino, Ballabio (CR26) 2007; 39
Thiery (CR27) 2002; 2
Kim, Lee, Lee (CR43) 2009; 54
Yuan, Chen, Wu (CR6) 2009; 15
Liu, Li, Semenov (CR34) 2002; 108
Fang, Ireton, Zhuang (CR47) 2008; 121
Miyazawa, Iwaya, Kroda (CR39) 2000; 437
Micalizzi, Farabaugh, Ford (CR12) 2010; 15
Nieto (CR28) 2009; 53
Ireton (CR4) 2005; 5
Wang, Fokas, Bieker (CR22) 2008; 19
Song, Mazurek, Liu (CR35) 2009; 69
19101799 - Dig Dis Sci. 2009 Nov;54(11):2410-7
11955436 - Cell. 2002 Mar 22;108(6):837-47
20490631 - J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):117-34
19531623 - Clin Cancer Res. 2009 Jul 1;15(13):4423-30
19048396 - Pathol Oncol Res. 2009 Sep;15(3):473-8
15892616 - Curr Cancer Drug Targets. 2005 May;5(3):149-57
19270647 - Mod Pathol. 2009 May;22(5):668-78
9514091 - Clin Exp Metastasis. 1998 Feb;16(2):105-12
19247945 - Int J Dev Biol. 2009;53(8-10):1541-7
19784072 - Oncogene. 2010 Jan 7;29(1):128-38
19945376 - Cell. 2009 Nov 25;139(5):871-90
20862283 - PLoS One. 2010 Sep 16;5(9):null
15297418 - Clin Cancer Res. 2004 Aug 1;10(15):5145-50
15621988 - Ann Surg. 2005 Jan;241(1):27-39
19396818 - Cancer. 2009 Jun 15;115(12):2684-92
19190323 - Cancer Res. 2009 Feb 15;69(4):1343-9
19309396 - Histopathology. 2009 Mar;54(4):442-51
12439911 - World J Gastroenterol. 2002 Dec;8(6):987-93
11147171 - Virchows Arch. 2000 Nov;437(5):508-13
20563765 - Tumour Biol. 2010 Dec;31(6):549-58
16969087 - Cancer Biol Ther. 2006 Oct;5(10):1357-60
17154180 - Cancer. 2007 Jan 15;109(2):332-40
10910081 - Cancer Res. 2000 Jul 1;60(13):3650-4
14965363 - Cancer Sci. 2004 Feb;95(2):136-41
19169796 - Cancer Metastasis Rev. 2009 Jun;28(1-2):15-33
12892963 - Lancet. 2003 Jul 26;362(9380):305-15
19642143 - Int J Cancer. 2010 Feb 15;126(4):940-9
19788698 - Hepatol Res. 2009 Dec;39(12):1169-77
12750294 - Cancer Res. 2003 May 15;63(10):2658-64
12189386 - Nat Rev Cancer. 2002 Jun;2(6):442-54
18198190 - J Cell Sci. 2008 Feb 1;121(Pt 3):358-68
16098727 - Curr Opin Cell Biol. 2005 Oct;17(5):548-58
20119975 - J Surg Oncol. 2010 Apr 1;101(5):356-62
18443431 - Cancer Biol Ther. 2008 Jul;7(7):1098-103
18097589 - Oncol Rep. 2008 Jan;19(1):151-6
18591935 - Oncogene. 2008 Oct 9;27(46):6044-55
17224647 - Cancer Biol Ther. 2007 Feb;6(2):269-75
19619488 - Dev Cell. 2009 Jul;17(1):9-26
20591914 - J Clin Pathol. 2010 Jul;63(7):635-9
16481735 - Cancer Biol Ther. 2006 Feb;5(2):228-33
21187520 - Anticancer Res. 2010 Dec;30(12):5239-43
20404114 - J Cell Biol. 2010 Apr 19;189(2):339-52
19153669 - Cancer Metastasis Rev. 2009 Jun;28(1-2):151-66
17558857 - Pathology. 2007 Jun;39(3):305-18
14977843 - Clin Cancer Res. 2004 Feb 15;10(4):1401-8
8978342 - Gastroenterology. 1997 Jan;112(1):46-54
11309274 - Cancer Res. 2001 Apr 15;61(8):3250-5
M Yilmaz (127_CR29) 2009; 28
YG Lin (127_CR15) 2007; 109
MA Huber (127_CR13) 2005; 17
PR Almeida (127_CR30) 2010; 63
L Prudkin (127_CR18) 2009; 22
XD Cui (127_CR20) 2010; 126
Q Wang (127_CR38) 2010; 29
S Song (127_CR35) 2009; 69
P Hohenberger (127_CR1) 2003; 362
C Liu (127_CR34) 2002; 108
Y Zhou (127_CR31) 2010; 31
AR Hess (127_CR48) 2006; 5
PH Thaker (127_CR14) 2004; 10
JM Brannan (127_CR21) 2009; 15
AA Kamat (127_CR23) 2009; 115
JM Benjamin (127_CR11) 2010; 189
WM Merrit (127_CR24) 2006; 5
M Guarino (127_CR32) 2007; 39
WJ Yuan (127_CR49) 2009; 54
H Kataoka (127_CR25) 2004; 95
M Lovatt (127_CR37) 2010; 5
YN Zhou (127_CR40) 2002; 8
Y Zhou (127_CR17) 2007; 6
C Gilles (127_CR46) 2003; 63
W Yuan (127_CR6) 2009; 15
HP Hsu (127_CR42) 2010; 101
MA Nieto (127_CR28) 2009; 53
C Lu (127_CR5) 2008; 7
P Yang (127_CR19) 2009; 39
M Polette (127_CR45) 1998; 16
Y Fuyuhiro (127_CR44) 2010; 30
DS Micalizzi (127_CR12) 2010; 15
BJ Dicken (127_CR2) 2005; 241
BT MacDonald (127_CR33) 2009; 17
MA Kim (127_CR43) 2009; 54
A Jawhari (127_CR16) 1997; 112
RC Ireton (127_CR4) 2005; 5
K Miyazawa (127_CR39) 2000; 437
M Guarino (127_CR26) 2007; 39
JP Thiery (127_CR27) 2002; 2
K Tomita (127_CR9) 2000; 60
DS Micalizzi (127_CR8) 2010; 15
AR Hess (127_CR3) 2001; 61
R Fukuyama (127_CR36) 2008; 27
LF Wang (127_CR22) 2008; 19
SC Wong (127_CR41) 2004; 10
WB Fang (127_CR47) 2008; 121
O Schmalhofer (127_CR10) 2009; 28
JP Thiery (127_CR7) 2009; 139
References_xml – volume: 31
  start-page: 549
  year: 2010
  end-page: 558
  ident: CR31
  article-title: Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer
  publication-title: Tumour Biol
  doi: 10.1007/s13277-010-0068-y
  contributor:
    fullname: Wu
– volume: 63
  start-page: 635
  year: 2010
  end-page: 639
  ident: CR30
  article-title: E-cadherin immunoexpression patterns in the characterisation of gastric carcinoma histotypes
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.2010.076026
  contributor:
    fullname: Santos
– volume: 15
  start-page: 117
  year: 2010
  end-page: 134
  ident: CR12
  article-title: Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression
  publication-title: J Mammary Gland Biol Neoplasia.
  doi: 10.1007/s10911-010-9178-9
  contributor:
    fullname: Ford
– volume: 22
  start-page: 668
  year: 2009
  end-page: 678
  ident: CR18
  article-title: Epithelial–mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung
  publication-title: Mod Pathol.
  doi: 10.1038/modpathol.2009.19
  contributor:
    fullname: Ozburn
– volume: 126
  start-page: 940
  year: 2010
  end-page: 949
  ident: CR20
  article-title: EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma
  publication-title: Int J Cancer
  contributor:
    fullname: Yu
– volume: 115
  start-page: 2684
  year: 2009
  end-page: 2692
  ident: CR23
  article-title: EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer
  publication-title: Cancer.
  doi: 10.1002/cncr.24335
  contributor:
    fullname: Merritt
– volume: 39
  start-page: 305
  year: 2007
  end-page: 318
  ident: CR26
  article-title: The role of epithelial-mesenchymal transition in cancer pathology
  publication-title: Pathology.
  doi: 10.1080/00313020701329914
  contributor:
    fullname: Ballabio
– volume: 39
  start-page: 1169
  year: 2009
  end-page: 1177
  ident: CR19
  article-title: Overexpression of EphA2, MMP-9 and MVD-CD34 in hepatocellular carcinoma: implications for tumor progression and prognosis
  publication-title: Heptol Res.
  doi: 10.1111/j.1872-034X.2009.00563.x
  contributor:
    fullname: He
– volume: 2
  start-page: 442
  year: 2002
  end-page: 454
  ident: CR27
  article-title: Epithelial-mesenchymal transition in tumor progression
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc822
  contributor:
    fullname: Thiery
– volume: 39
  start-page: 305
  year: 2007
  end-page: 318
  ident: CR32
  article-title: The role of epithelial–mesenchymal transition in cancer pathology
  publication-title: Pathology.
  doi: 10.1080/00313020701329914
  contributor:
    fullname: Ballabio
– volume: 5
  start-page: 1357
  year: 2006
  end-page: 1360
  ident: CR24
  article-title: Analysis of EphA2 expression and mutant p53 in ovarian carcinoma
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.5.10.3225
  contributor:
    fullname: Landen
– volume: 10
  start-page: 1401
  year: 2004
  end-page: 1408
  ident: CR41
  article-title: Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-0157-03
  contributor:
    fullname: Lee
– volume: 27
  start-page: 6044
  year: 2008
  end-page: 6055
  ident: CR36
  article-title: Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription
  publication-title: Oncogene.
  doi: 10.1038/onc.2008.204
  contributor:
    fullname: Ng
– volume: 8
  start-page: 987
  year: 2002
  end-page: 993
  ident: CR40
  article-title: Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival
  publication-title: World J Gastroenterol
  contributor:
    fullname: Han
– volume: 61
  start-page: 3250
  year: 2001
  end-page: 3255
  ident: CR3
  article-title: Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2)
  publication-title: Cancer Res
  contributor:
    fullname: Gardner
– volume: 7
  start-page: 1098
  year: 2008
  end-page: 1103
  ident: CR5
  article-title: EphA2 overexpression promotes ovarian cancer growth
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.7.7.6168
  contributor:
    fullname: Wang
– volume: 69
  start-page: 1343
  year: 2009
  end-page: 1349
  ident: CR35
  article-title: Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-4153
  contributor:
    fullname: Liu
– volume: 15
  start-page: 4423
  year: 2009
  end-page: 4430
  ident: CR21
  article-title: Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-09-0473
  contributor:
    fullname: Prudkin
– volume: 121
  start-page: 358
  year: 2008
  end-page: 368
  ident: CR47
  article-title: Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism
  publication-title: J Cell Sci
  doi: 10.1242/jcs.017145
  contributor:
    fullname: Zhuang
– volume: 101
  start-page: 356
  year: 2010
  end-page: 362
  ident: CR42
  article-title: Loss of E-cadherin and beta-catenin is correlated with poor prognosis of ampullary neoplasms
  publication-title: J Surg Oncol
  contributor:
    fullname: Jin
– volume: 5
  start-page: 149
  year: 2005
  end-page: 157
  ident: CR4
  article-title: Chen J: EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics
  publication-title: Curr Cancer Drug Targets.
  doi: 10.2174/1568009053765780
  contributor:
    fullname: Ireton
– volume: 139
  start-page: 871
  year: 2009
  end-page: 890
  ident: CR7
  article-title: Epithelial–mesenchymal transitions in development and disease
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.007
  contributor:
    fullname: Huang
– volume: 189
  start-page: 339
  year: 2010
  end-page: 352
  ident: CR11
  article-title: AlphaE-catenin regulates actin dynamics independently of cadherin-mediated cell–cell adhesion
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200910041
  contributor:
    fullname: Yang
– volume: 95
  start-page: 136
  year: 2004
  end-page: 141
  ident: CR25
  article-title: Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer
  publication-title: Cancer Sci
  doi: 10.1111/j.1349-7006.2004.tb03194.x
  contributor:
    fullname: Kanamori
– volume: 60
  start-page: 3650
  year: 2000
  end-page: 3654
  ident: CR9
  article-title: Cadherin switching in human prostate cancer progression
  publication-title: Cancer Res
  contributor:
    fullname: van Leenders
– volume: 241
  start-page: 27
  year: 2005
  end-page: 39
  ident: CR2
  article-title: Gastric adenocarcinoma: review and considerations for future directions
  publication-title: Ann Surg
  contributor:
    fullname: Cass
– volume: 108
  start-page: 837
  year: 2002
  end-page: 847
  ident: CR34
  article-title: Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00685-2
  contributor:
    fullname: Semenov
– volume: 63
  start-page: 2658
  year: 2003
  end-page: 2664
  ident: CR46
  article-title: Transactivation of vimentin by beta-catenin in human breast cancer cells
  publication-title: Cancer Res
  contributor:
    fullname: Mestdagt
– volume: 362
  start-page: 305
  year: 2003
  end-page: 315
  ident: CR1
  article-title: Gastric cancer
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)13975-X
  contributor:
    fullname: Gretschel
– volume: 53
  start-page: 1541
  year: 2009
  end-page: 1547
  ident: CR28
  article-title: Epithelial–mesenchymal transitions in development and disease: old views and new perspectives
  publication-title: Int J Dev Biol
  doi: 10.1387/ijdb.072410mn
  contributor:
    fullname: Nieto
– volume: 112
  start-page: 46
  year: 1997
  end-page: 54
  ident: CR16
  article-title: Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(97)70218-X
  contributor:
    fullname: Poole
– volume: 437
  start-page: 508
  year: 2000
  end-page: 513
  ident: CR39
  article-title: Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: correlation with early tumor invasion
  publication-title: Virchows Arch
  doi: 10.1007/s004280000283
  contributor:
    fullname: Kroda
– volume: 109
  start-page: 332
  year: 2007
  end-page: 340
  ident: CR15
  article-title: EphA2 overexpression is associated with angiogenesis in ovarian cancer
  publication-title: Cancer.
  doi: 10.1002/cncr.22415
  contributor:
    fullname: Kamat
– volume: 17
  start-page: 9
  year: 2009
  end-page: 26
  ident: CR33
  article-title: Wnt/beta-catenin signaling: components, mechanisms, and diseases
  publication-title: Dev Cell.
  doi: 10.1016/j.devcel.2009.06.016
  contributor:
    fullname: He
– volume: 5
  start-page: e12794
  year: 2010
  ident: CR37
  article-title: Stabilisation of β-catenin downstream of T cell receptor signaling
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0012794
  contributor:
    fullname: Bijlmakers
– volume: 15
  start-page: 473
  year: 2009
  end-page: 478
  ident: CR6
  article-title: Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis
  publication-title: Pathol Oncol Res.
  doi: 10.1007/s12253-008-9132-y
  contributor:
    fullname: Wu
– volume: 30
  start-page: 5239
  year: 2010
  end-page: 5243
  ident: CR44
  article-title: Clinical significance of vimentin-positive gastric cancer cells
  publication-title: Anticancer Res
  contributor:
    fullname: Noda
– volume: 6
  start-page: 269
  year: 2007
  end-page: 275
  ident: CR17
  article-title: Effect of celecoxib on E-cadherin, VEGF. Microvessel density and apoptosis in gastric cancer
  publication-title: Cancer Biol Ther.
  contributor:
    fullname: Tang
– volume: 16
  start-page: 105
  year: 1998
  end-page: 112
  ident: CR45
  article-title: Association of fibroblastoid features with the invasive phenotype in human bronchial cancer cell lines
  publication-title: Clin Exp Metastasis
  doi: 10.1023/A:1006572204497
  contributor:
    fullname: de Bentzmann
– volume: 28
  start-page: 15
  year: 2009
  end-page: 33
  ident: CR29
  article-title: EMT, the cytoskeleton, and cancer cell invasion
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-008-9169-0
  contributor:
    fullname: Christofori
– volume: 15
  start-page: 117
  year: 2010
  end-page: 134
  ident: CR8
  article-title: Epithelial–mesenchymal transition in cancer: parallels between normal development and tumor progression
  publication-title: J Mammary Gland Biol Neoplasia.
  doi: 10.1007/s10911-010-9178-9
  contributor:
    fullname: Ford
– volume: 19
  start-page: 151
  year: 2008
  end-page: 156
  ident: CR22
  article-title: Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients
  publication-title: Oncol Rep
  contributor:
    fullname: Bieker
– volume: 54
  start-page: 442
  year: 2009
  end-page: 451
  ident: CR43
  article-title: Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2009.03247.x
  contributor:
    fullname: Lee
– volume: 28
  start-page: 151
  year: 2009
  end-page: 166
  ident: CR10
  article-title: E-cadherin beta-catenin and ZEB1 in malignant progression of cancer
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-008-9179-y
  contributor:
    fullname: Brabletz
– volume: 54
  start-page: 2410
  year: 2009
  end-page: 2417
  ident: CR49
  article-title: Over-expression of EphA2 and EphrinA-1 in human gastric adenocarcinoma and its prognostic value for postoperative patients
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-008-0649-4
  contributor:
    fullname: Chen
– volume: 17
  start-page: 548
  year: 2005
  end-page: 558
  ident: CR13
  article-title: Molecular requirements for epithelial-mesenchymal transition during tumor progression
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/j.ceb.2005.08.001
  contributor:
    fullname: Beug
– volume: 29
  start-page: 128
  year: 2010
  end-page: 138
  ident: CR38
  article-title: Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells
  publication-title: Oncogene.
  doi: 10.1038/onc.2009.302
  contributor:
    fullname: Allgayer
– volume: 5
  start-page: 228
  year: 2006
  end-page: 233
  ident: CR48
  article-title: VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.5.2.2510
  contributor:
    fullname: Gruman
– volume: 10
  start-page: 5145
  year: 2004
  end-page: 5150
  ident: CR14
  article-title: EphA2 expression is associated with aggressive features in ovarian carcinoma
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-03-0589
  contributor:
    fullname: Celestino
– volume: 5
  start-page: 149
  year: 2005
  ident: 127_CR4
  publication-title: Curr Cancer Drug Targets.
  doi: 10.2174/1568009053765780
  contributor:
    fullname: RC Ireton
– volume: 7
  start-page: 1098
  year: 2008
  ident: 127_CR5
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.7.7.6168
  contributor:
    fullname: C Lu
– volume: 5
  start-page: e12794
  year: 2010
  ident: 127_CR37
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0012794
  contributor:
    fullname: M Lovatt
– volume: 126
  start-page: 940
  year: 2010
  ident: 127_CR20
  publication-title: Int J Cancer
  doi: 10.1002/ijc.24798
  contributor:
    fullname: XD Cui
– volume: 95
  start-page: 136
  year: 2004
  ident: 127_CR25
  publication-title: Cancer Sci
  doi: 10.1111/j.1349-7006.2004.tb03194.x
  contributor:
    fullname: H Kataoka
– volume: 39
  start-page: 1169
  year: 2009
  ident: 127_CR19
  publication-title: Heptol Res.
  doi: 10.1111/j.1872-034X.2009.00563.x
  contributor:
    fullname: P Yang
– volume: 108
  start-page: 837
  year: 2002
  ident: 127_CR34
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00685-2
  contributor:
    fullname: C Liu
– volume: 10
  start-page: 1401
  year: 2004
  ident: 127_CR41
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-0157-03
  contributor:
    fullname: SC Wong
– volume: 139
  start-page: 871
  year: 2009
  ident: 127_CR7
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.007
  contributor:
    fullname: JP Thiery
– volume: 8
  start-page: 987
  year: 2002
  ident: 127_CR40
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v8.i6.987
  contributor:
    fullname: YN Zhou
– volume: 54
  start-page: 2410
  year: 2009
  ident: 127_CR49
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-008-0649-4
  contributor:
    fullname: WJ Yuan
– volume: 437
  start-page: 508
  year: 2000
  ident: 127_CR39
  publication-title: Virchows Arch
  doi: 10.1007/s004280000283
  contributor:
    fullname: K Miyazawa
– volume: 61
  start-page: 3250
  year: 2001
  ident: 127_CR3
  publication-title: Cancer Res
  contributor:
    fullname: AR Hess
– volume: 28
  start-page: 151
  year: 2009
  ident: 127_CR10
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-008-9179-y
  contributor:
    fullname: O Schmalhofer
– volume: 39
  start-page: 305
  year: 2007
  ident: 127_CR32
  publication-title: Pathology.
  doi: 10.1080/00313020701329914
  contributor:
    fullname: M Guarino
– volume: 16
  start-page: 105
  year: 1998
  ident: 127_CR45
  publication-title: Clin Exp Metastasis
  doi: 10.1023/A:1006572204497
  contributor:
    fullname: M Polette
– volume: 189
  start-page: 339
  year: 2010
  ident: 127_CR11
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200910041
  contributor:
    fullname: JM Benjamin
– volume: 15
  start-page: 4423
  year: 2009
  ident: 127_CR21
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-09-0473
  contributor:
    fullname: JM Brannan
– volume: 27
  start-page: 6044
  year: 2008
  ident: 127_CR36
  publication-title: Oncogene.
  doi: 10.1038/onc.2008.204
  contributor:
    fullname: R Fukuyama
– volume: 30
  start-page: 5239
  year: 2010
  ident: 127_CR44
  publication-title: Anticancer Res
  contributor:
    fullname: Y Fuyuhiro
– volume: 362
  start-page: 305
  year: 2003
  ident: 127_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)13975-X
  contributor:
    fullname: P Hohenberger
– volume: 109
  start-page: 332
  year: 2007
  ident: 127_CR15
  publication-title: Cancer.
  doi: 10.1002/cncr.22415
  contributor:
    fullname: YG Lin
– volume: 39
  start-page: 305
  year: 2007
  ident: 127_CR26
  publication-title: Pathology.
  doi: 10.1080/00313020701329914
  contributor:
    fullname: M Guarino
– volume: 22
  start-page: 668
  year: 2009
  ident: 127_CR18
  publication-title: Mod Pathol.
  doi: 10.1038/modpathol.2009.19
  contributor:
    fullname: L Prudkin
– volume: 112
  start-page: 46
  year: 1997
  ident: 127_CR16
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(97)70218-X
  contributor:
    fullname: A Jawhari
– volume: 15
  start-page: 117
  year: 2010
  ident: 127_CR8
  publication-title: J Mammary Gland Biol Neoplasia.
  doi: 10.1007/s10911-010-9178-9
  contributor:
    fullname: DS Micalizzi
– volume: 53
  start-page: 1541
  year: 2009
  ident: 127_CR28
  publication-title: Int J Dev Biol
  doi: 10.1387/ijdb.072410mn
  contributor:
    fullname: MA Nieto
– volume: 17
  start-page: 9
  year: 2009
  ident: 127_CR33
  publication-title: Dev Cell.
  doi: 10.1016/j.devcel.2009.06.016
  contributor:
    fullname: BT MacDonald
– volume: 15
  start-page: 473
  year: 2009
  ident: 127_CR6
  publication-title: Pathol Oncol Res.
  doi: 10.1007/s12253-008-9132-y
  contributor:
    fullname: W Yuan
– volume: 10
  start-page: 5145
  year: 2004
  ident: 127_CR14
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-03-0589
  contributor:
    fullname: PH Thaker
– volume: 2
  start-page: 442
  year: 2002
  ident: 127_CR27
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc822
  contributor:
    fullname: JP Thiery
– volume: 101
  start-page: 356
  year: 2010
  ident: 127_CR42
  publication-title: J Surg Oncol
  doi: 10.1002/jso.21493
  contributor:
    fullname: HP Hsu
– volume: 15
  start-page: 117
  year: 2010
  ident: 127_CR12
  publication-title: J Mammary Gland Biol Neoplasia.
  doi: 10.1007/s10911-010-9178-9
  contributor:
    fullname: DS Micalizzi
– volume: 54
  start-page: 442
  year: 2009
  ident: 127_CR43
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2009.03247.x
  contributor:
    fullname: MA Kim
– volume: 31
  start-page: 549
  year: 2010
  ident: 127_CR31
  publication-title: Tumour Biol
  doi: 10.1007/s13277-010-0068-y
  contributor:
    fullname: Y Zhou
– volume: 115
  start-page: 2684
  year: 2009
  ident: 127_CR23
  publication-title: Cancer.
  doi: 10.1002/cncr.24335
  contributor:
    fullname: AA Kamat
– volume: 63
  start-page: 635
  year: 2010
  ident: 127_CR30
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.2010.076026
  contributor:
    fullname: PR Almeida
– volume: 17
  start-page: 548
  year: 2005
  ident: 127_CR13
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/j.ceb.2005.08.001
  contributor:
    fullname: MA Huber
– volume: 121
  start-page: 358
  year: 2008
  ident: 127_CR47
  publication-title: J Cell Sci
  doi: 10.1242/jcs.017145
  contributor:
    fullname: WB Fang
– volume: 29
  start-page: 128
  year: 2010
  ident: 127_CR38
  publication-title: Oncogene.
  doi: 10.1038/onc.2009.302
  contributor:
    fullname: Q Wang
– volume: 69
  start-page: 1343
  year: 2009
  ident: 127_CR35
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-4153
  contributor:
    fullname: S Song
– volume: 63
  start-page: 2658
  year: 2003
  ident: 127_CR46
  publication-title: Cancer Res
  contributor:
    fullname: C Gilles
– volume: 28
  start-page: 15
  year: 2009
  ident: 127_CR29
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-008-9169-0
  contributor:
    fullname: M Yilmaz
– volume: 5
  start-page: 228
  year: 2006
  ident: 127_CR48
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.5.2.2510
  contributor:
    fullname: AR Hess
– volume: 6
  start-page: 269
  year: 2007
  ident: 127_CR17
  publication-title: Cancer Biol Ther.
  doi: 10.4161/cbt.6.2.3629
  contributor:
    fullname: Y Zhou
– volume: 19
  start-page: 151
  year: 2008
  ident: 127_CR22
  publication-title: Oncol Rep
  contributor:
    fullname: LF Wang
– volume: 5
  start-page: 1357
  year: 2006
  ident: 127_CR24
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.5.10.3225
  contributor:
    fullname: WM Merrit
– volume: 60
  start-page: 3650
  year: 2000
  ident: 127_CR9
  publication-title: Cancer Res
  contributor:
    fullname: K Tomita
– volume: 241
  start-page: 27
  year: 2005
  ident: 127_CR2
  publication-title: Ann Surg
  doi: 10.1097/01.sla.0000149300.28588.23
  contributor:
    fullname: BJ Dicken
SSID ssj0021529
Score 2.2211497
Snippet The expression of EphA2 and three epithelial–mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry...
The expression of EphA2 and three epithelial-mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry...
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 2691
SubjectTerms Adult
Aged
beta Catenin - analysis
Cadherins - analysis
Epithelial-Mesenchymal Transition
Female
Hematology
Humans
Internal Medicine
Lymphatic Metastasis
Male
Medicine
Medicine & Public Health
Middle Aged
Neoplasm Staging
Oncology
Original Paper
Pathology
Prognosis
Receptor, EphA2 - analysis
Receptor, EphA2 - physiology
Stomach Neoplasms - chemistry
Stomach Neoplasms - mortality
Stomach Neoplasms - pathology
Stomach Neoplasms - surgery
Vimentin - analysis
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwELaqIqFeEBQKC6UaJE5UrrKO194cV6hVVanthZV6i8aOQ1d0vVF3K8GNd-ApeC2ehBknm1KVHnqOY1v6xp5vPH9CfCSWWyjMnDTaBqm1R-lsVkiPrlJ1XeHIcHLy6Zk5nuqTi9HFhlD900X8drD2SKaL-jbXjXt9y_SiN1RW0rX7hLiD5jCuqZr0RhbpoyIZWSMrSbn3nsz_TXFXF90jmPeco0nnHD0XzzqyCJMW3RdiI8Rt8fS0c4e_FL_PSRDD9y6WNcKihsPmcqLAc8-NK6aRwA-tEBpOvbgiWfvz89ecE4785Y85Tb1iVZWitmT7QwWpcsMsLmEW4StyWw8PnmXjGjBWkDwLPIgj9GhfMJsnCk8DgAgwNFypowltQXHoyrYuX4np0eGXz8ey670gfW7VipOqyZAbY14TJawy5W3QfuyI3RiC0FqnMQy5kXrh6yJPhQfR5AaHtQ8Ygs13xGZcxPBGAF2gPnOoQ65Rj43BzLsKC2-r3DvMzUB8WqNQNm2JjfK2mDJDVhJkJUNWqoHYXeNUdqdtyV70EQfMaPr8of9M54SdHxjD4maZLJ0xsauM1nvd4tuvpojnFETlBmJ_Dfi_kz-wlbePGv1ObBHXUm0kzK7YXF3fhPfEZ1ZuLwnwX7z88hc
  priority: 102
  providerName: Springer Nature
Title Overexpression of EphA2 correlates with epithelial–mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients
URI https://link.springer.com/article/10.1007/s12032-011-0127-2
https://www.ncbi.nlm.nih.gov/pubmed/22189617
https://www.proquest.com/docview/1095199742
https://search.proquest.com/docview/1111863506
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fa9swEBdd-7KXsdJ1y9aWG-xpQ-DIihQ_jaykLSttx2ggezInWV4DjePVKWyfaF9zd7KTrJTtyWALSfhOut_9F-IdodxMYeKk0TZIrT1KZ5NMenSFKssCB4aTky8uzdlEf54Opp3BrenCKld3Yryoi4VnGzmdbsICGaFf9bH-IblrFHtXuxYaT8ROXxHzEj_b6UbhItmURYVrYCUJ-rVXM6bOcetwGQ2EfWWleiiXHoHNR47SKH9OnotnHXCEUUvpXbEVqj3x-4o4MfzsglkrWJQwrm9GCjw33bhlHAlsaYVQc-7FLTGbnHO-kb_5NafZliypYtCWbIcXEAs3zKoGZhV8R-7q4cEza9wBVgVExwIP4gA92grM5hHB0wAg_As1F-qoQ1tPHLqqrc0LMTkZXx-fya71gvSpVUvOqSY9bohpSYiwSJS3QfuhI3BjiILWOo2hz33UM19maaw7iCY12C99wBBsui-2q0UVXgmg-9MnDnVINeqhMZh4V2DmbZF6h6npiferH5_XbYWNfFNLmamUE5VyplKueuJgRZq8O2xNvmGNnni7_kzHhH0fWIXFfRMVnSGBq4TWe9mSdL2aIpiTEZLriQ8rGv89-T-28vr_W3kjnhK2Um3ky4HYXt7dh0PCL0t3FJn0SOyMTr-dj-n5aXz55Su9najRHxb39T8
link.rule.ids 315,783,787,12070,21402,27938,27939,31733,31734,33758,33759,41095,41537,42164,42606,43324,43819,52125,52248,74081,74638
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Rb9MwELZgPMALAjGgMLZD4mnIUuq4dvOEJrSp29rxskl9i86OwyqtaWhaCX4Rf5M7J22HJniOZVu5s-873913QnwilJspTJw02gaptUfpbJJJj65QZVngwHBx8uTKjG70xXQw7R7cmi6tcnMnxou6WHh-I6fTTVggI_SrvtQ_JHeN4uhq10LjsXjCPFzMnW-nO4eLbFMWHa6BlWTot1HNWDrHrcNlfCDsKyvV33bpAdh8ECiN9ufshXjeAUc4aSX9UjwK1Svx-xtpYvjZJbNWsCjhtL49UeC56cYd40jgl1YINdde3JGyyTnXG_nbX3OabcWWKiZtyXZ4AZG4YVY1MKvgO3JXDw-eVWMJWBUQAws8iBP0aCswm0cETwOA8C_UTNRRh5ZPHDrW1mZf3JydXn8dya71gvSpVSuuqSY_bohpSYiwSJS3QfuhI3BjSILWOo2hz33UM19maeQdRJMa7Jc-YAg2fS32qkUV3gqg-9MnDnVINeqhMZh4V2DmbZF6h6npiePNj8_rlmEj33Eps5RyklLOUspVTxxsRJN3h63Jd6rREx-3n-mYcOwDq7BYN9HRGRK4Smi9N61It6spgjkZIbme-LyR8f3J_7GVd__fypF4OrqejPPx-dXle_GMcJZqs2AOxN5quQ4fCMus3GFU2D-wqvQY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELZokVAvCFQeKQUGiRPIYuN17OwJVdCoDygcqJTbauz1tpGazdJNJfhF_E1mvE4CquC8lm3tN_Z843kJ8ZpYbqEwc9JoG6TWHqWzWSE9ukrVdYUjw8nJn8_M0bk-mY6mKf6pS2GVqzsxXtTVwvMbOZ1u4gIFsV_1rk5hEV8_Tt633yV3kGJPa2qnsSXuWk2KjmTbTjfGF-mpIhpfIytJ6a89nDGNjtuIy_hYOFRWqr911C3iectpGnXR5IG4n0gkHPSoPxR3QrMrfn0hqQw_UmBrA4saDtvLAwWeG3BcMacEfnWF0HIexhUJnpxz7pG__Dmn2ZastWIAl-yHVxCLOMyaDmYNXCB3-PDgWUyuAZsKopOBB3GwHm0FZvPI5mkAEBeGlot2tKGvLQ6pgmv3SJxPDr99OJKpDYP0uVVLzq8mm26MeU3ssMqUt0H7sSOiYwhNa53GMOSe6oWvizzWIESTGxzWPmAINn8stptFE54KoLvUZw51yDXqsTGYeVdh4W2Ve4e5GYg3qx9ftn21jXJTV5lRKgmlklEq1UDsr6Ap08Hryo2YDMSr9Wc6MuwHwSYsbrpo9IyJaGW03pMe0vVqiihPQaxuIN6uMP5z8n9sZe__W3kp7pGslp-Oz06fiR2iXKoPiNkX28vrm_CcaM3SvYjy-hsDGPhN
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Overexpression+of+EphA2+correlates+with+epithelial-mesenchymal+transition-related+proteins+in+gastric+cancer+and+their+prognostic+importance+for+postoperative+patients&rft.jtitle=Medical+oncology+%28Northwood%2C+London%2C+England%29&rft.au=Hou%2C+Futao&rft.au=Yuan%2C+Weijie&rft.au=Huang%2C+Jin&rft.au=Qian%2C+Liyuan&rft.date=2012-12-01&rft.eissn=1559-131X&rft.volume=29&rft.issue=4&rft.spage=2691&rft.epage=2700&rft_id=info:doi/10.1007%2Fs12032-011-0127-2&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1357-0560&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1357-0560&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1357-0560&client=summon